Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Globalisation

Aesica predicts more CMO consolidation and hints at acquisitions

17-Mar-2014 - Aesica has predicted that CMO sector consolidation will continue and hinted that it is considering strategic acquisitions as a part of a bid to generate $1bn revenue.

breaking news - update 2

CRL to buy Argenta and Biofocus from Galapagos for €134m

13-Mar-2014 - Preclinical CRO Charles River Labs has announced plans to buy discovery services firms Argenta and BioFocus from Galapagos NV.

CDSCO analysis reveals prevalence of substandard drugs in India

11-Mar-2014 - Nearly a quarter of drugs made in Jammu & Kashmir and 10% of those produced in Himachal Pradesh are substandard according to new testing data published by CDSCO. 

WuXi reveals steep increase in quarterly manufacturing revenues

10-Mar-2014 - WuXi PharmaTech has revealed that demand for its manufacturing services increased significantly last year and forecast that its "open access" approach will help it sustain growth into 2014. 

Exclusive interview

INC Research expands into Middle East with MEK acquisition

10-Mar-2014 - In a sign of further consolidation, CRO INC Research has acquired CRO MEK Consulting and will absorb its more than 40 employees based in the Middle East and north Africa.

Demand for labs that can handle deadly viruses is catching says TNO

03-Mar-2014 - Scientists developing vaccines for potentially deadly diseases like influenza, SARS and HIV struggle to find a CRO with the right capabilities according to contractor TNO Triskelion.

PPD deals to increase presence in expanding German trials sector

25-Feb-2014 - CRO Pharmaceutical Product Development (PPD) and the Charité – Universitätsmedizin hospital in Berlin are collaborating to increase the volume of clinical trials conducted in Germany.

Icon: FY13 bolstered by M&A strategy, bolt-on acqusitions to continue

24-Feb-2014 - Icon says it intends to continue its M&A strategy focusing on capabilities, geographies and technologies as it reports a robust 2013.

DKSH gets the Glory citing increased demand for Asian expansion services

19-Feb-2014 - DKSH has acquired Macau-based distributor Glory and says demand for Asian market access is being driven from both Western and local pharma firms.

Parexel tops analysts’ revenue, EPS expectations for Q2

03-Feb-2014 - Parexel narrowly beat investment analysts’ earnings per share and revenue expectations as consolidated service revenue hit $487.1m.

Quintiles says size matters when it comes to strategic deals

22-Jan-2014 - CEO Tom Pike emphasised Quintiles’ credentials as a Big Pharma collaborator and highlighted personalised medicines as a key driver for the CRO at an investment conference last week.

AMRI targeting higher tech manufacturing and generics as Burlington booms

20-Jan-2014 - AMRI says it intends to expand its fill/finish capability and progress its business into higher value technology following the recent all clear at its once troubled Burlington facility.

CRL looks to strategic alliances to drive growth across changing clientbase

20-Jan-2014 - Strategic relationships with both big pharma and mid-tier firms will drive future growth, says Charles River laboratories (CRL).

Wuxi slightly raises financial expectations for 2013

20-Jan-2014 - WuXi PharmaTech has raised its 2013 financial guidance and now expects to achieve total revenues for 2013 of approximately $578m (€424m). 

AMEC to expand pharma plant design biz with $3bn Foster Wheeler buy

13-Jan-2014 - AMEC has announced its plan to buy US  firm Foster Wheeler AG for $3.2bn (€2.3bn) in a deal that includes the latter’s pharmaceutical plant design services business.

Recipharm to sell drug co-developed with Astimex, signs new manufacturing deal

18-Dec-2013 - CMO Recipharm has set out to sell a new own-brand infectious disease medication it developed in partnership with fellow Sweden-based firm Astimex Pharma.

GSK mulls making target-free sales model a requirement for contractors

18-Dec-2013 - Contract sales and marketing people who want to work for GSK should think about adopting the new target-free remuneration policy the UK pharmaceutical firm outlined earlier this week.

China PDX market growing PDQ: Crown Bioscience to set up mouse trial centre

11-Dec-2013 - The increasingly crowded Chinese preclinical model market gained a new entrant last month with US preclinical CRO Crown Bioscience partnering with Shanghai academics to set up a research centre.

Venn continues growth with $1.1m purchase of Northern Irish CRO

10-Dec-2013 - Venn Life Sciences has purchased Belfast, UK CRO Medevol in its second acquisition in as many months.

US FDA sued for alleged 'unlawful' detention of API batch destined for CMO

05-Dec-2013 - A lawsuit alleging that the US FDA unlawfully detained a batch of acetaminophen API destined for CMO Gemini Pharmaceuticals could have significant impact on the drug industry's definition of an...

Patheon announces UK expansion and posts improved financials for fiscal 2013

03-Dec-2013 - Soon to merge CMO Patheon has increased solid dosage form production capacity at its site in the UK and posted an improved set of preliminary results for the financial year.

Dispatches from PCT

Regulatory costs will rise, fines will increase, expert warns

21-Nov-2013 - Economic uncertainty and a bleak fiscal outlook will lead to over-regulation and increased fines in the clinical trial industry, according to an economic expert at PCT.

PCT - Day 2

Ultravox wrong: Vienna 'everything' to CROs this week

19-Nov-2013 - CROs from across Europe and beyond have gathered in Vienna, Austria this week for Partnerships in Clinical Trials' (PCT) European congress. will be covering the show live.

Venn acquires German CRO and says there's more to come

18-Nov-2013 - Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.

News in brief

Catalent clinical supply plant opens its doors in China

18-Nov-2013 - Catalent has cut the ribbon on its Clinical Supply facility in China just months after construction began.